ENTRY       D10570            Mixture   Drug
NAME        Insulin degludec (genetical recombination) and insulin aspart (genetical recombination);
            Ryzodeg (TN)
COMPONENT   Insulin degludec (genetical recombination) [DR:D09727], Insulin aspart (genetical recombination) [DR:D04475]
CLASS       Antidiabetic agent
             DG01636  Insulin preparation
REMARK      Therapeutic category: 2492
            ATC code: A10AD06
            Product: D10570<JP>
EFFICACY    Antidiabetic, Insulin receptor agonist
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10A INSULINS AND ANALOGUES
                A10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting
                 A10AD06 Insulin degludec and insulin aspart
                  D10570  Insulin degludec (genetical recombination) and insulin aspart (genetical recombination) &lt;JP&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Insulins
               Insulin, Long-acting
                Insulin Aspart/ Insulin Degludec
                 D10570  Insulin degludec (genetical recombination) and insulin aspart (genetical recombination)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              24  Hormones
               249  Miscellaneous
                2492  Pancreatic hormones
                 D10570  Insulin degludec (genetical recombination) and insulin aspart (genetical recombination)
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG01636  Insulin preparation
               D10570  Insulin degludec and insulin aspart (genetical recombination)
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG01636  Insulin preparation
               D10570  Insulin degludec and insulin aspart (genetical recombination)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10570
DBLINKS     PubChem: 254741532
///
